Benitec Biopharma Inc.BNTCEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference (ddRNAi) technology.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Averill Master Fund, Ltd. | 44.15% | 12.7M | ▼ -0.45pp | 2024-11-18 |
| Franklin Resources, Inc. | 22.90% | 588.2K | ▼ -5.60pp | 2023-12-11 |
| S.S. OR | 11.60% | 2.7M | ▲ +3.30pp | 2024-12-06 |
| HBM Healthcare Investments | 9.99% | 849.9K | — | 2024-04-29 |
| Adage Capital Partners, L.P. | 9.99% | 264.5K | ▲ +2.49pp | 2024-04-11 |
| NOS. OF ABOVE PERSONS | 9.99% | 262.8K | — | 2024-02-13 |
| HBM | 9.70% | 1.0M | — | 2024-11-13 |
| Nemean Asset Management, LLC | 8.39% | 746.3K | ▲ +4.50pp | 2024-04-29 |
| Citadel Advisors LLC | 3.40% | 2.7M | ▼ -3.50pp | 2024-02-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.